Anorexia nervosa, often referred to simply as anorexia, is an eating disorder characterized by low weight, food restriction, fear of gaining weight, and an overpowering desire to be thin. Many people with anorexia see themselves as overweight although they are, in fact, underweight. The DSM-5 describe this perceptual symptom like "disturbance in the way in which one’s body weight or shape is experienced. In research this symptom is called "body image disturbance". Patients with anorexia nervosa also often deny that they have a problem with low weight. They may weigh themselves frequently, eat small amounts, or only eat certain foods. Some exercise excessively, force themselves to vomit (in the "anorexia purging" subtype), or use laxatives to lose weight. Complications may include osteoporosis, infertility, and heart damage, among others. Women will often stop having menstrual periods. In extreme cases, people with anorexia who continually refuse significant dietary intake and weight restoration interventions, and are declared incompetent to make decisions by a psychiatrist, may be fed by force under restraint via nasogastric tube after asking their parents or proxies to make the decision for them.
|"Miss A—" depicted in 1866 and in 1870 after treatment. She was one of the earliest case studies of anorexia. From the published medical papers of Sir William Gull.|
|Specialty||Psychiatry, Clinical psychology|
|Symptoms||Low weight, fear of gaining weight, strong desire to be thin, food restrictions|
|Complications||Osteoporosis, infertility, heart damage, suicide|
|Usual onset||Teen years to young adulthood|
|Risk factors||Family history, high-level athletics, modelling, dancing|
|Differential diagnosis||Body dysmorphic disorder, bulimia nervosa, substance use disorder, hyperthyroidism, inflammatory bowel disease, dysphagia, cancer|
|Treatment||Cognitive behavioral therapy, hospitalisation to restore weight|
|Prognosis||5% risk of death over 10 years|
|Frequency||2.9 million (2015)|
The cause of anorexia is currently unknown. There appear to be some genetic components with identical twins more often affected than fraternal twins. Cultural factors also appear to play a role, with societies that value thinness having higher rates of the disease. Additionally, it occurs more commonly among those involved in activities that value thinness, such as high-level athletics, modeling, and dancing. Anorexia often begins following a major life-change or stress-inducing event. The diagnosis requires a significantly low weight. The severity of disease is based on body mass index (BMI) in adults with mild disease having a BMI of greater than 17, moderate a BMI of 16 to 17, severe a BMI of 15 to 16, and extreme a BMI less than 15. In children, a BMI for age percentile of less than the 5th percentile is often used.
Treatment of anorexia involves restoring the patient back to a healthy weight, treating their underlying psychological problems, and addressing behaviors that promote the problem. While medications do not help with weight gain, they may be used to help with associated anxiety or depression. Different therapy methods may be useful, such as cognitive behavioral therapy or an approach where parents assume responsibility for feeding their child, known as Maudsley family therapy. Sometimes people require admission to a hospital to restore weight. Evidence for benefit from nasogastric tube feeding is unclear; such an intervention may be highly distressing for both anorexia patients and healthcare staff when administered against the patient's will under restraint. Some people with anorexia will have a single episode and recover while others may have recurring episodes over years. Many complications improve or resolve with the regaining of weight.
Globally, anorexia is estimated to affect 2.9 million people as of 2015. It is estimated to occur in 0.9% to 4.3% of women and 0.2% to 0.3% of men in Western countries at some point in their life. About 0.4% of young women are affected in a given year and it is estimated to occur ten times more commonly among women than men. Rates in most of the developing world are unclear. Often it begins during the teen years or young adulthood. While anorexia became more commonly diagnosed during the 20th century it is unclear if this was due to an increase in its frequency or simply better diagnosis. In 2013, it directly resulted in about 600 deaths globally, up from 400 deaths in 1990. Eating disorders also increase a person's risk of death from a wide range of other causes, including suicide. About 5% of people with anorexia die from complications over a ten-year period, a nearly six times increased risk. The term "anorexia nervosa" was first used in 1873 by William Gull to describe this condition.
In recent years, evolutionary psychiatry as an emerging scientific discipline has been studying mental disorders from an evolutionary perspective. It is still debated whether eating disorders such as anorexia have evolutionary functions or if they are problems resulting from a modern lifestyle.
Signs and symptoms
Anorexia nervosa is an eating disorder characterized by attempts to lose weight to the point of starvation. A person with anorexia nervosa may exhibit a number of signs and symptoms, the type and severity of which may vary and be present but not readily apparent.
Anorexia nervosa, and the associated malnutrition that results from self-imposed starvation, can cause complications in every major organ system in the body. Hypokalaemia, a drop in the level of potassium in the blood, is a sign of anorexia nervosa. A significant drop in potassium can cause abnormal heart rhythms, constipation, fatigue, muscle damage, and paralysis.
Signs and symptoms may include:
- A low body mass index for one's age and height.
- Amenorrhea, a symptom that occurs after prolonged weight loss, causing menstruation to stop, hair to become brittle, and skin to become yellow and unhealthy.
- Fear of even the slightest weight gain; taking all precautionary measures to avoid weight gain or becoming "overweight".
- Rapid, continuous weight loss.
- Lanugo: soft, fine hair growing over the face and body.
- An obsession with counting calories and monitoring fat contents of food.
- Preoccupation with food, recipes, or cooking; may cook elaborate dinners for others, but not eat the food themselves or consume a very small portion.
- Food restrictions despite being underweight or at a healthy weight.
- Food rituals, such as cutting food into tiny pieces, refusing to eat around others, and hiding or discarding of food.
- Purging: may use laxatives, diet pills, ipecac syrup, or water pills to flush food out of their system after eating or engage in self-induced vomiting, though this is a more common symptom of bulimia.
- Excessive exercise, including micro-exercising, for example making small persistent movements of fingers or toes.
- Perception of self as overweight, in contradiction to an underweight reality (called "body image disturbance" )
- Intolerance to cold and frequent complaints of being cold; body temperature may lower (hypothermia) in an effort to conserve energy due to malnutrition.
- Hypotension or orthostatic hypotension.
- Bradycardia or tachycardia.
- Depression, anxiety disorders and insomnia.
- Solitude: may avoid friends and family and become more withdrawn and secretive.
- Abdominal distension.
- Halitosis (from vomiting or starvation-induced ketosis).
- Dry hair and skin, as well as hair thinning.
- Chronic fatigue.
- Rapid mood swings.
- Orange discoloration of the skin, particularly the feet (Carotenosis).
- Having severe muscle tension, aches and pains.
- Evidence/habits of self harming or self-loathing.
- Admiration of thinner people.
Interoception involves the conscious and unconscious sense of the internal state of the body, and it has an important role in homeostasis and regulation of emotions. Aside from noticeable physiological dysfunction, interoceptive deficits also prompt individuals with anorexia to concentrate on distorted perceptions of multiple elements of their body image. This exists in both people with anorexia and in healthy individuals due to impairment in interoceptive sensitivity and interoceptive awareness.
Aside from weight gain and outer appearance, people with anorexia also report abnormal bodily functions such as indistinct feelings of fullness. This provides an example of miscommunication between internal signals of the body and the brain. Due to impaired interoceptive sensitivity, powerful cues of fullness may be detected prematurely in highly sensitive individuals, which can result in decreased calorie consumption and generate anxiety surrounding food intake in anorexia patients. People with anorexia also report difficulty identifying and describing their emotional feelings and the inability to distinguish emotions from bodily sensations in general, called alexithymia.
Interoceptive awareness and emotion are deeply intertwined, and could mutually impact each other in abnormalities. Anorexia patients also exhibit emotional regulation difficulties that ignite emotionally-cued eating behaviors, such as restricting food or excessive exercising. Impaired interoceptive sensitivity and interoceptive awareness can lead anorexia patients to adapt distorted interpretations of weight gain that are cued by physical sensations related to digestion (e.g., fullness). Combined, these interoceptive and emotional elements could together trigger maladaptive and negatively reinforced behavioral responses that assist in the maintenance of anorexia. In addition to metacognition, people with anorexia also have difficulty with social cognition including interpreting others’ emotions, and demonstrating empathy. Abnormal interoceptive awareness and interoceptive sensitivity shown through all of these examples have been observed so frequently in anorexia that they have become key characteristics of the illness.
Other psychological issues may factor into anorexia nervosa; some fulfill the criteria for a separate Axis I diagnosis or a personality disorder which is coded Axis II and thus are considered comorbid to the diagnosed eating disorder. Some people have a previous disorder which may increase their vulnerability to developing an eating disorder and some develop them afterwards. The presence of Axis I or Axis II psychiatric comorbidity has been shown to affect the severity and type of anorexia nervosa symptoms in both adolescents and adults.
Obsessive-compulsive disorder (OCD) and obsessive-compulsive personality disorder (OCPD) are highly comorbid with AN. OCPD is linked with more severe symptomatology and worse prognosis. The causality between personality disorders and eating disorders has yet to be fully established. Other comorbid conditions include depression, alcoholism, borderline and other personality disorders, anxiety disorders, attention deficit hyperactivity disorder, and body dysmorphic disorder (BDD). Depression and anxiety are the most common comorbidities, and depression is associated with a worse outcome.
Autism spectrum disorders occur more commonly among people with eating disorders than in the general population. Zucker et al. (2007) proposed that conditions on the autism spectrum make up the cognitive endophenotype underlying anorexia nervosa and appealed for increased interdisciplinary collaboration.
Anorexia nervosa is highly heritable. Twin studies have shown a heritability rate of between 28 and 58%. First-degree relatives of those with anorexia have roughly 12 times the risk of developing anorexia. Association studies have been performed, studying 128 different polymorphisms related to 43 genes including genes involved in regulation of eating behavior, motivation and reward mechanics, personality traits and emotion. Consistent associations have been identified for polymorphisms associated with agouti-related peptide, brain derived neurotrophic factor, catechol-o-methyl transferase, SK3 and opioid receptor delta-1. Epigenetic modifications, such as DNA methylation, may contribute to the development or maintenance of anorexia nervosa, though clinical research in this area is in its infancy.
A 2019 study found a genetic relationship with mental disorders, such as schizophrenia, obsessive–compulsive disorder, anxiety disorder and depression; and metabolic functioning with a negative correlation with fat mass, type 2 diabetes and leptin.
Obstetric complications: prenatal and perinatal complications may factor into the development of anorexia nervosa, such as preterm birth, maternal anemia, diabetes mellitus, preeclampsia, placental infarction, and neonatal heart abnormalities. Neonatal complications may also have an influence on harm avoidance, one of the personality traits associated with the development of AN.
Neuroendocrine dysregulation: altered signalling of peptides that facilitate communication between the gut, brain and adipose tissue, such as ghrelin, leptin, neuropeptide Y and orexin, may contribute to the pathogenesis of anorexia nervosa by disrupting regulation of hunger and satiety.
Gastrointestinal diseases: people with gastrointestinal disorders may be more at risk of developing disorders of eating practices than the general population, principally restrictive eating disturbances. An association of anorexia nervosa with celiac disease has been found. The role that gastrointestinal symptoms play in the development of eating disorders seems rather complex. Some authors report that unresolved symptoms prior to gastrointestinal disease diagnosis may create a food aversion in these persons, causing alterations to their eating patterns. Other authors report that greater symptoms throughout their diagnosis led to greater risk. It has been documented that some people with celiac disease, irritable bowel syndrome or inflammatory bowel disease who are not conscious about the importance of strictly following their diet, choose to consume their trigger foods to promote weight loss. On the other hand, individuals with good dietary management may develop anxiety, food aversion and eating disorders because of concerns around cross contamination of their foods. Some authors suggest that medical professionals should evaluate the presence of an unrecognized celiac disease in all people with eating disorder, especially if they present any gastrointestinal symptom (such as decreased appetite, abdominal pain, bloating, distension, vomiting, diarrhea or constipation), weight loss, or growth failure; and also routinely ask celiac patients about weight or body shape concerns, dieting or vomiting for weight control, to evaluate the possible presence of eating disorders, especially in women.
Studies have hypothesized the continuance of disordered eating patterns may be epiphenomena of starvation. The results of the Minnesota Starvation Experiment showed normal controls exhibit many of the behavioral patterns of AN when subjected to starvation. This may be due to the numerous changes in the neuroendocrine system, which results in a self-perpetuating cycle.
Anorexia nervosa is more likely to occur in a person's pubertal years. Some explanatory hypotheses for the rising prevalence of eating disorders in adolescence are "increase of adipose tissue in girls, hormonal changes of puberty, societal expectations of increased independence and autonomy that are particularly difficult for anorexic adolescents to meet; [and] increased influence of the peer group and its values."
Early theories of the cause of anorexia linked it to childhood sexual abuse or dysfunctional families; evidence is conflicting, and well-designed research is needed. The fear of food is known as sitiophobia or cibophobia, and is part of the differential diagnosis. Other psychological causes of anorexia include low self-esteem, feeling like there is lack of control, depression, anxiety, and loneliness. Anorexic people are, in general, highly perfectionistic and most have an obsessive compulsive personality traits which may facilitate sticking to a restricted diet. It has been suggested that anorexic patients are rigid in their thought patterns, and place a high level of importance upon being thin.
Anorexia nervosa has been increasingly diagnosed since 1950; the increase has been linked to vulnerability and internalization of body ideals. People in professions where there is a particular social pressure to be thin (such as models and dancers) were more likely to develop anorexia, and those with anorexia have much higher contact with cultural sources that promote weight loss. This trend can also be observed for people who partake in certain sports, such as jockeys and wrestlers. There is a higher incidence and prevalence of anorexia nervosa in sports with an emphasis on aesthetics, where low body fat is advantageous, and sports in which one has to make weight for competition. Family group dynamics can play a role in the cause of anorexia including negative expressed emotion in overprotective families where blame is frequently experienced among its members. When there is a constant pressure from people to be thin, teasing and bullying can cause low self-esteem and other psychological symptoms.
Persistent exposure to media that presents body ideals may constitute a risk factor for body dissatisfaction and anorexia nervosa. The cultural ideal for body shape for men versus women continues to favor slender women and athletic, V-shaped muscular men. A 2002 review found that, of the magazines most popular among people aged 18 to 24 years, those read by men, unlike those read by women, were more likely to feature ads and articles on shape than on diet. Body dissatisfaction and internalization of body ideals are risk factors for anorexia nervosa that threaten the health of both male and female populations.
Websites that stress the importance of attainment of body ideals extol and promote anorexia nervosa through the use of religious metaphors, lifestyle descriptions, "thinspiration" or "fitspiration" (inspirational photo galleries and quotes that aim to serve as motivators for attainment of body ideals). Pro-anorexia websites reinforce internalization of body ideals and the importance of their attainment.
The media portray a false view of what people truly look like. In magazines and movies and even on billboards most of the actors/models are digitally altered in multiple ways. People then strive to look like these "perfect" role models when in reality they are not near perfection themselves.
Evidence from physiological, pharmacological and neuroimaging studies suggest serotonin (also called 5-HT) may play a role in anorexia. While acutely ill, metabolic changes may produce a number of biological findings in people with anorexia that are not necessarily causative of the anorexic behavior. For example, abnormal hormonal responses to challenges with serotonergic agents have been observed during acute illness, but not recovery. Nevertheless, increased cerebrospinal fluid concentrations of 5-hydroxyindoleacetic acid (a metabolite of serotonin), and changes in anorectic behavior in response to acute tryptophan depletion (tryptophan is a metabolic precursor to serotonin) support a role in anorexia. The activity of the 5-HT2A receptors has been reported to be lower in patients with anorexia in a number of cortical regions, evidenced by lower binding potential of this receptor as measured by PET or SPECT, independent of the state of illness. While these findings may be confounded by comorbid psychiatric disorders, taken as a whole they indicate serotonin in anorexia. These alterations in serotonin have been linked to traits characteristic of anorexia such as obsessiveness, anxiety, and appetite dysregulation.
Neuroimaging studies investigating the functional connectivity between brain regions have observed a number of alterations in networks related to cognitive control, introspection, and sensory function. Alterations in networks related to the dorsal anterior cingulate cortex may be related to excessive cognitive control of eating related behaviors. Similarly, altered somatosensory integration and introspection may relate to abnormal body image. A review of functional neuroimaging studies reported reduced activations in "bottom up" limbic region and increased activations in "top down" cortical regions which may play a role in restrictive eating.
Compared to controls, recovered anorexics show reduced activation in the reward system in response to food, and reduced correlation between self reported liking of a sugary drink and activity in the striatum and anterior cingulate cortex. Increased binding potential of 11C radiolabelled raclopride in the striatum, interpreted as reflecting decreased endogenous dopamine due to competitive displacement, has also been observed.
Structural neuroimaging studies have found global reductions in both gray matter and white matter, as well as increased cerebrospinal fluid volumes. Regional decreases in the left hypothalamus, left inferior parietal lobe, right lentiform nucleus and right caudate have also been reported in acutely ill patients. However, these alterations seem to be associated with acute malnutrition and largely reversible with weight restoration, at least in nonchronic cases in younger people. In contrast, some studies have reported increased orbitofrontal cortex volume in currently ill and in recovered patients, although findings are inconsistent. Reduced white matter integrity in the fornix has also been reported.
A diagnostic assessment includes the person's current circumstances, biographical history, current symptoms, and family history. The assessment also includes a mental state examination, which is an assessment of the person's current mood and thought content, focusing on views on weight and patterns of eating.
Anorexia nervosa is classified under the Feeding and Eating Disorders in the latest revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM 5). There is no specific BMI cutoff that defines low weight required for the diagnosis of anorexia nervosa.
- Restriction of energy intake relative to requirements leading to a low body weight.
- Intense fear of gaining weight or persistent behaviors that interfere with gaining weight.
- Disturbance in the way a person's weight or body shape is experienced or a lack of recognition about the risks of the low body weight.
Relative to the previous version of the DSM (DSM-IV-TR), the 2013 revision (DSM5) reflects changes in the criteria for anorexia nervosa, most notably that of the amenorrhea criterion being removed. Amenorrhea was removed for several reasons: it does not apply to males, it is not applicable for females before or after the age of menstruation or taking birth control pills, and some women who meet the other criteria for AN still report some menstrual activity.
- Binge-eating/purging type: the individual utilizes binge eating or displays purging behavior as a means for losing weight. It is different from bulimia nervosa in terms of the individual's weight. An individual with binge-eating/purging type anorexia can maintain a healthy or normal weight, but is usually significantly underweight. People with bulimia nervosa on the other hand can sometimes be overweight.
- Restricting type: the individual uses restricting food intake, fasting, diet pills, or exercise as a means for losing weight; they may exercise excessively to keep off weight or prevent weight gain, and some individuals eat only enough to stay alive. In the restrictive type, there are no recurrent episodes of binge-eating or purging present.
Levels of severity
Body mass index (BMI) is used by the DSM-5 as an indicator of the level of severity of anorexia nervosa. The DSM-5 states these as follows:
- Mild: BMI of greater than 17
- Moderate: BMI of 16–16.99
- Severe: BMI of 15–15.99
- Extreme: BMI of less than 15
Medical tests to check for signs of physical deterioration in anorexia nervosa may be performed by a general physician or psychiatrist, including:
- Complete Blood Count (CBC): a test of the white blood cells, red blood cells and platelets used to assess the presence of various disorders such as leukocytosis, leukopenia, thrombocytosis and anemia which may result from malnutrition.
- Urinalysis: a variety of tests performed on the urine used in the diagnosis of medical disorders, to test for substance abuse, and as an indicator of overall health
- Chem-20: Chem-20 also known as SMA-20 a group of twenty separate chemical tests performed on blood serum. Tests include cholesterol, protein and electrolytes such as potassium, chlorine and sodium and tests specific to liver and kidney function.
- Glucose tolerance test: Oral glucose tolerance test (OGTT) used to assess the body's ability to metabolize glucose. Can be useful in detecting various disorders such as diabetes, an insulinoma, Cushing's Syndrome, hypoglycemia and polycystic ovary syndrome.
- Serum cholinesterase test: a test of liver enzymes (acetylcholinesterase and pseudocholinesterase) useful as a test of liver function and to assess the effects of malnutrition.
- Liver Function Test: A series of tests used to assess liver function some of the tests are also used in the assessment of malnutrition, protein deficiency, kidney function, bleeding disorders, and Crohn's Disease.
- Luteinizing hormone (LH) response to gonadotropin-releasing hormone (GnRH): Tests the pituitary glands' response to GnRh, a hormone produced in the hypothalamus. Hypogonadism is often seen in anorexia nervosa cases.
- Creatine kinase (CK) test: measures the circulating blood levels of creatine kinase an enzyme found in the heart (CK-MB), brain (CK-BB) and skeletal muscle (CK-MM).
- Blood urea nitrogen (BUN) test: urea nitrogen is the byproduct of protein metabolism first formed in the liver then removed from the body by the kidneys. The BUN test is primarily used to test kidney function. A low BUN level may indicate the effects of malnutrition.
- BUN-to-creatinine ratio: A BUN to creatinine ratio is used to predict various conditions. A high BUN/creatinine ratio can occur in severe hydration, acute kidney failure, congestive heart failure, and intestinal bleeding. A low BUN/creatinine ratio can indicate a low protein diet, celiac disease, rhabdomyolysis, or cirrhosis of the liver.
- Electrocardiogram (EKG or ECG): measures electrical activity of the heart. It can be used to detect various disorders such as hyperkalemia.
- Electroencephalogram (EEG): measures the electrical activity of the brain. It can be used to detect abnormalities such as those associated with pituitary tumors.
- Thyroid screen: test used to assess thyroid functioning by checking levels of thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3).
A variety of medical and psychological conditions have been misdiagnosed as anorexia nervosa; in some cases the correct diagnosis was not made for more than ten years.
The distinction between the diagnosis of anorexia nervosa, bulimia nervosa and eating disorder not otherwise specified (EDNOS) is often difficult to make as there is considerable overlap between people diagnosed with these conditions. Seemingly minor changes in people's overall behavior or attitude can change a diagnosis from anorexia: binge-eating type to bulimia nervosa. A main factor differentiating binge-purge anorexia from bulimia is the gap in physical weight. Someone with bulimia nervosa is ordinarily at a healthy weight, or slightly overweight. Someone with binge-purge anorexia is commonly underweight. People with the binge-purging subtype of AN may be significantly underweight and typically do not binge-eat large amounts of food, yet they purge the small amount of food they eat. In contrast, those with bulimia nervosa tend to be at normal weight or overweight and binge large amounts of food. It is not unusual for a person with an eating disorder to "move through" various diagnoses as their behavior and beliefs change over time.
There is no conclusive evidence that any particular treatment for anorexia nervosa works better than others; however, there is enough evidence to suggest that early intervention and treatment are more effective. Treatment for anorexia nervosa tries to address three main areas.
- Restoring the person to a healthy weight;
- Treating the psychological disorders related to the illness;
- Reducing or eliminating behaviors or thoughts that originally led to the disordered eating.
Although restoring the person's weight is the primary task at hand, optimal treatment also includes and monitors behavioral change in the individual as well. There is some evidence that hospitalization might adversely affect long term outcome.
Psychotherapy for individuals with AN is challenging as they may value being thin and may seek to maintain control and resist change. Some studies demonstrate that family based therapy in adolescents with AN is superior to individual therapy. Due to the nature of the condition, treatment of people with AN can be difficult because they are afraid of gaining weight. Initially developing a desire to change is important.
Diet is the most essential factor to work on in people with anorexia nervosa, and must be tailored to each person's needs. Food variety is important when establishing meal plans as well as foods that are higher in energy density. People must consume adequate calories, starting slowly, and increasing at a measured pace. Evidence of a role for zinc supplementation during refeeding is unclear.
Family-based treatment (FBT) has been shown to be more successful than individual therapy for adolescents with AN. Various forms of family-based treatment have been proven to work in the treatment of adolescent AN including conjoint family therapy (CFT), in which the parents and child are seen together by the same therapist, and separated family therapy (SFT) in which the parents and child attend therapy separately with different therapists. Proponents of family therapy for adolescents with AN assert that it is important to include parents in the adolescent's treatment.
A four- to five-year follow up study of the Maudsley family therapy, an evidence-based manualized model, showed full recovery at rates up to 90%. Although this model is recommended by the NIMH, critics claim that it has the potential to create power struggles in an intimate relationship and may disrupt equal partnerships.
Cognitive behavioral therapy (CBT) is useful in adolescents and adults with anorexia nervosa; acceptance and commitment therapy is a type of CBT, which has shown promise in the treatment of AN. Cognitive remediation therapy (CRT) is used in treating anorexia nervosa.
Pharmaceuticals have limited benefit for anorexia itself. There is a lack of good information from which to make recommendations concerning the effectiveness of antidepressants in treating anorexia. Administration of olanzapine has been shown to result in a modest but statistically significant increase in body weight of anorexia nervosa patients.
Admission to hospital
AN has a high mortality and patients admitted in a severely ill state to medical units are at particularly high risk. Diagnosis can be challenging, risk assessment may not be performed accurately, consent and the need for compulsion may not be assessed appropriately, refeeding syndrome may be missed or poorly treated and the behavioural and family problems in AN may be missed or poorly managed. Guidelines published by the Royal College of Psychiatrists recommend that medical and psychiatric experts work together in managing severely ill people with AN.
The rate of refeeding can be difficult to establish, because the fear of refeeding syndrome (RFS) can lead to underfeeding. It is thought that RFS, with falling phosphate and potassium levels, is more likely to occur when BMI is very low, and when medical comorbidities such as infection or cardiac failure, are present. In those circumstances, it is recommended to start refeeding slowly but to build up rapidly as long as RFS does not occur. Recommendations on energy requirements vary, from 5–10 kcal/kg/day in the most medically compromised patients, who appear to have the highest risk of RFS, to 1900 kcal/day.
AN has the highest mortality rate of any psychological disorder. The mortality rate is 11 to 12 times greater than in the general population, and the suicide risk is 56 times higher. Half of women with AN achieve a full recovery, while an additional 20–30% may partially recover. Not all people with anorexia recover completely: about 20% develop anorexia nervosa as a chronic disorder. If anorexia nervosa is not treated, serious complications such as heart conditions and kidney failure can arise and eventually lead to death. The average number of years from onset to remission of AN is seven for women and three for men. After ten to fifteen years, 70% of people no longer meet the diagnostic criteria, but many still continue to have eating-related problems.
Alexithymia influences treatment outcome. Recovery is also viewed on a spectrum rather than black and white. According to the Morgan-Russell criteria, individuals can have a good, intermediate, or poor outcome. Even when a person is classified as having a "good" outcome, weight only has to be within 15% of average, and normal menstruation must be present in females. The good outcome also excludes psychological health. Recovery for people with anorexia nervosa is undeniably positive, but recovery does not mean a return to normal.
Anorexia nervosa can have serious implications if its duration and severity are significant and if onset occurs before the completion of growth, pubertal maturation, or the attainment of peak bone mass. Complications specific to adolescents and children with anorexia nervosa can include the following: Growth retardation may occur, as height gain may slow and can stop completely with severe weight loss or chronic malnutrition. In such cases, provided that growth potential is preserved, height increase can resume and reach full potential after normal intake is resumed. Height potential is normally preserved if the duration and severity of illness are not significant or if the illness is accompanied by delayed bone age (especially prior to a bone age of approximately 15 years), as hypogonadism may partially counteract the effects of undernutrition on height by allowing for a longer duration of growth compared to controls. Appropriate early treatment can preserve height potential, and may even help to increase it in some post-anorexic subjects, due to factors such as long-term reduced estrogen-producing adipose tissue levels compared to premorbid levels. In some cases, especially where onset is before puberty, complications such as stunted growth and pubertal delay are usually reversible.
Anorexia nervosa causes alterations in the female reproductive system; significant weight loss, as well as psychological stress and intense exercise, typically results in a cessation of menstruation in women who are past puberty. In patients with anorexia nervosa, there is a reduction of the secretion of gonadotropin releasing hormone in the central nervous system, preventing ovulation. Anorexia nervosa can also result in pubertal delay or arrest. Both height gain and pubertal development are dependent on the release of growth hormone and gonadotropins (LH and FSH) from the pituitary gland. Suppression of gonadotropins in people with anorexia nervosa has been documented. Typically, growth hormone (GH) levels are high, but levels of IGF-1, the downstream hormone that should be released in response to GH are low; this indicates a state of “resistance” to GH due to chronic starvation. IGF-1 is necessary for bone formation, and decreased levels in anorexia nervosa contribute to a loss of bone density and potentially contribute to osteopenia or osteoporosis. Anorexia nervosa can also result in reduction of peak bone mass. Buildup of bone is greatest during adolescence, and if onset of anorexia nervosa occurs during this time and stalls puberty, low bone mass may be permanent.
Hepatic steatosis, or fatty infiltration of the liver, can also occur, and is an indicator of malnutrition in children. Neurological disorders that may occur as complications include seizures and tremors. Wernicke encephalopathy, which results from vitamin B1 deficiency, has been reported in patients who are extremely malnourished; symptoms include confusion, problems with the muscles responsible for eye movements and abnormalities in walking gait.
The most common gastrointestinal complications of anorexia nervosa are delayed stomach emptying and constipation, but also include elevated liver function tests, diarrhea, acute pancreatitis, heartburn, difficulty swallowing, and, rarely, superior mesenteric artery syndrome. Delayed stomach emptying, or gastroparesis, often develops following food restriction and weight loss; the most common symptom is bloating with gas and abdominal distension, and often occurs after eating. Other symptoms of gastroparesis include early satiety, fullness, nausea, and vomiting. The symptoms may inhibit efforts at eating and recovery, but can be managed by limiting high-fiber foods, using liquid nutritional supplements, or using metoclopramide to increase emptying of food from the stomach. Gastroparesis generally resolves when weight is regained.
Anorexia nervosa increases the risk of sudden cardiac death, though the precise cause is unknown. Cardiac complications include structural and functional changes to the heart. Some of these cardiovascular changes are mild and are reversible with treatment, while others may be life-threatening. Cardiac complications can include arrhythmias, abnormally slow heart beat, low blood pressure, decreased size of the heart muscle, reduced heart volume, mitral valve prolapse, myocardial fibrosis, and pericardial effusion.
Abnormalities in conduction and repolarization of the heart that can result from anorexia nervosa include QT prolongation, increased QT dispersion, conduction delays, and junctional escape rhythms. Electrolyte abnormalities, particularly hypokalemia and hypomagnesemia, can cause anomalies in the electrical activity of the heart, and result in life-threatening arrhythmias. Hypokalemia most commonly results in anorexic patients when restricting is accompanied by purging (induced vomiting or laxative use). Hypotension (low blood pressure) is common, and symptoms include fatigue and weakness. Orthostatic hypotension, a marked decrease in blood pressure when standing from a supine position, may also occur. Symptoms include lightheadedness upon standing, weakness, and cognitive impairment, and may result in fainting or near-fainting. Orthostasis in anorexia nervosa indicates worsening cardiac function and may indicate a need for hospitalization. Hypotension and orthostasis generally resolve upon recovery to a normal weight. The weight loss in anorexia nervosa also causes atrophy of cardiac muscle. This leads to decreased ability to pump blood, a reduction in the ability to sustain exercise, a diminished ability to increase blood pressure in response to exercise, and a subjective feeling of fatigue.
Some individuals may also have a decrease in cardiac contractility. Cardiac complications can be life-threatening, but the heart muscle generally improves with weight gain, and the heart normalizes in size over weeks to months, with recovery. Atrophy of the heart muscle is a marker of the severity of the disease, and while it is reversible with treatment and refeeding, it is possible that it may cause permanent, microscopic changes to the heart muscle that increase the risk of sudden cardiac death. Individuals with anorexia nervosa may experience chest pain or palpitations; these can be a result of mitral valve prolapse. Mitral valve prolapse occurs because the size of the heart muscle decreases while the tissue of the mitral valve remains the same size. Studies have shown rates of mitral valve prolapse of around 20 percent in those with anorexia nervosa, while the rate in the general population is estimated at 2–4 percent. It has been suggested that there is an association between mitral valve prolapse and sudden cardiac death, but it has not been proven to be causative, either in patients with anorexia nervosa or in the general population.
Anorexia is estimated to occur in 0.9% to 4.3% of women and 0.2% to 0.3% of men in Western countries at some point in their life. About 0.4% of young females are affected in a given year and it is estimated to occur three to ten times less commonly in males. Rates in most of the developing world are unclear. Often it begins during the teen years or young adulthood.
The lifetime rate of atypical anorexia nervosa, a form of ED-NOS in which the person loses a significant amount of weight and is at risk for serious medical complications despite having a higher body-mass index, is much higher, at 5–12%.
While anorexia became more commonly diagnosed during the 20th century it is unclear if this was due to an increase in its frequency or simply better diagnosis. Most studies show that since at least 1970 the incidence of AN in adult women is fairly constant, while there is some indication that the incidence may have been increasing for girls aged between 14 and 20. According to researcher Ben Radford who wrote in Skeptical Inquirer "I found many examples of flawed, misleading, and sometimes completely wrong information and data being copied and widely disseminated among eating disorder organizations and educators without anyone bothering to consult the original research to verify its accuracy". Radford states that misleading statistics and data have been ignored by organizations like the National Eating Disorder Association who has not released data for "incidence of anorexia from 1984–2017" he states that each agency continues to report incorrect numbers assuming that someone else has checked the accuracy.
Eating disorders are less reported in preindustrial, non-westernized countries than in Western countries. In Africa, not including South Africa, the only data presenting information about eating disorders occurs in case reports and isolated studies, not studies investigating prevalence. Data shows in research that in westernized civilizations, ethnic minorities have very similar rates of eating disorders, contrary to the belief that eating disorders predominantly occur in white people.
Men (and women) who might otherwise be diagnosed with anorexia may not meet the DSM IV criteria for BMI since they have muscle weight, but have very little fat. Male and female athletes are often overlooked as anorexic. Research emphasizes the importance to take athletes' diet, weight and symptoms into account when diagnosing anorexia, instead of just looking at weight and BMI. For athletes, ritualized activities such as weigh-ins place emphasis on gaining and losing large amounts of weight, which may promote the development of eating disorders among them. While women use diet pills, which is an indicator of unhealthy behavior and an eating disorder, men use steroids, which contextualizes the beauty ideals for genders. In a Canadian study, 4% of boys in grade nine used anabolic steroids. Anorexic men are sometimes referred to as manorexic.
Anorexia Nervosa and gender
Despite the stereotypes around eating disorders with women, one in three people with an eating disorder is male. This statistic may represent a minimum estimation. Due to the feminine stigma attached to anorexia, many men are hesitant to seek help and remain undiagnosed. Additionally, assessment tests are geared towards how anorexia is experienced in women, leading to misconceptions around how men experience anorexia. Some reports note a rise in men developing anorexia, however this may be explained by men feeling better able to seek help and wider recognition of the fact men experience eating disorders.
The term "anorexia nervosa" was coined in 1873 by Sir William Gull, one of Queen Victoria's personal physicians. The history of anorexia nervosa begins with descriptions of religious fasting dating from the Hellenistic era and continuing into the medieval period. The medieval practice of self-starvation by women, including some young women, in the name of religious piety and purity also concerns anorexia nervosa; it is sometimes referred to as anorexia mirabilis.
The earliest medical descriptions of anorexic illnesses are generally credited to English physician Richard Morton in 1689. Case descriptions fitting anorexic illnesses continued throughout the 17th, 18th, and 19th centuries.
In the late 19th century anorexia nervosa became widely accepted by the medical profession as a recognized condition. In 1873, Sir William Gull, one of Queen Victoria's personal physicians, published a seminal paper which coined the term "anorexia nervosa" and provided a number of detailed case descriptions and treatments. In the same year, French physician Ernest-Charles Lasègue similarly published details of a number of cases in a paper entitled De l'Anorexie hystérique.
Awareness of the condition was largely limited to the medical profession until the latter part of the 20th century, when German-American psychoanalyst Hilde Bruch published The Golden Cage: the Enigma of Anorexia Nervosa in 1978. Despite major advances in neuroscience, Bruch's theories tend to dominate popular thinking. A further important event was the death of the popular singer and drummer Karen Carpenter in 1983, which prompted widespread ongoing media coverage of eating disorders.
- Eating recovery
- Evolutionary psychiatry
- Idée fixe
- List of people with anorexia nervosa
- National Association of Anorexia Nervosa and Associated Disorders
- Orthorexia nervosa
- "What are Eating Disorders?". NIMH. Archived from the original on 23 May 2015. Retrieved 24 May 2015.
- Attia E (2010). "Anorexia nervosa: current status and future directions". Annual Review of Medicine. 61 (1): 425–35. doi:10.1146/annurev.med.050208.200745. PMID 19719398.
- Diagnostic and statistical manual of mental disorders : DSM-5 (5 ed.). Washington: American Psychiatric Publishing. 2013. pp. 338–345. ISBN 978-0-89042-555-8.
- Arcelus J, Witcomb GL, Mitchell A (March 2014). "Prevalence of eating disorders amongst dancers: a systemic review and meta-analysis". European Eating Disorders Review. 22 (2): 92–101. doi:10.1002/erv.2271. PMID 24277724.
- Parker R, Sharma A (2008). General Medicine. Elsevier Health Sciences. p. 56. ISBN 978-0723434610.
- First MB (19 November 2013). DSM-5 Handbook of Differential Diagnosis. American Psychiatric Pub. ISBN 9781585624621 – via Google Books.
- "Feeding and eating disorders" (PDF). American Psychiatric Publishing. 2013. Archived from the original (PDF) on 1 May 2015. Retrieved 9 April 2015.
- Espie J, Eisler I (2015). "Focus on anorexia nervosa: modern psychological treatment and guidelines for the adolescent patient". Adolescent Health, Medicine and Therapeutics. 6: 9–16. doi:10.2147/AHMT.S70300. PMC 4316908. PMID 25678834.
- Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
- Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
- Shepphird SF (2009). 100 Questions & Answers About Anorexia Nervosa. Jones & Bartlett Learning. p. xvi. ISBN 978-1-4496-3079-9. Archived from the original on 8 September 2017.
- Artoni, P.; Chierici, M. L.; Arnone, F.; Cigarini, C.; De Bernardis, E.; Galeazzi, G. M.; Minneci, D. G.; Scita, F.; Turrini, G.; De Bernardis, M.; Pingani, L. (March 2021). "Body perception treatment, a possible way to treat body image disturbance in eating disorders: a case-control efficacy study". Eating and weight disorders: EWD. 26 (2): 499–514. doi:10.1007/s40519-020-00875-x. ISSN 1590-1262. PMID 32124409.
- Kodua M, Mackenzie JM, Smyth N (December 2020). "Nursing assistants' experiences of administering manual restraint for compulsory nasogastric feeding of young persons with anorexia nervosa". International Journal of Mental Health Nursing. 29 (6): 1181–1191. doi:10.1111/inm.12758. PMID 32578949.
- "Proxy definition and meaning | Collins English Dictionary". www.collinsdictionary.com. Retrieved 2 October 2020.
- "Force-Feeding of Anorexic Patients and the Right to Die" (PDF).
- Hay P (July 2013). "A systematic review of evidence for psychological treatments in eating disorders: 2005-2012". The International Journal of Eating Disorders. 46 (5): 462–9. doi:10.1002/eat.22103. PMID 23658093.
- "Eating Disorders: Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders" (PDF). 2004. p. 103. PMID 23346610.
- Smink FR, van Hoeken D, Hoek HW (August 2012). "Epidemiology of eating disorders: incidence, prevalence and mortality rates". Current Psychiatry Reports. 14 (4): 406–14. doi:10.1007/s11920-012-0282-y. PMC 3409365. PMID 22644309.
- Murray CJ, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, et al. (GBD 2013 Mortality and Causes of Death Collaborators) (January 2015). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.
- Gull WW (September 1997). "Anorexia nervosa (apepsia hysterica, anorexia hysterica). 1868". Obesity Research. 5 (5): 498–502. doi:10.1002/j.1550-8528.1997.tb00677.x. PMID 9385628.
- Abed RT (December 1998). "The sexual competition hypothesis for eating disorders". The British Journal of Medical Psychology. 71 (4): 525–47. doi:10.1111/j.2044-8341.1998.tb01007.x. PMID 9875960.
- Nettersheim J, Gerlach G, Herpertz S, Abed R, Figueredo AJ, Brüne M (31 October 2018). "Evolutionary Psychology of Eating Disorders: An Explorative Study in Patients With Anorexia Nervosa and Bulimia Nervosa". Frontiers in Psychology. 9: 2122. doi:10.3389/fpsyg.2018.02122. PMC 6220092. PMID 30429818.
- Nesse RM (2019). Good reasons for bad feelings : insights from the frontier of evolutionary psychiatry. ISBN 978-1-101-98566-3. OCLC 1057242826.
- Surgenor LJ, Maguire S (2013). "Assessment of anorexia nervosa: an overview of universal issues and contextual challenges". Journal of Eating Disorders. 1 (1): 29. doi:10.1186/2050-2974-1-29. PMC 4081667. PMID 24999408.
- Strumia R (September 2009). "Skin signs in anorexia nervosa". Dermato-Endocrinology. 1 (5): 268–70. doi:10.4161/derm.1.5.10193. PMC 2836432. PMID 20808514.
- Miller KK (September 2013). "Endocrine effects of anorexia nervosa". Endocrinology and Metabolism Clinics of North America. 42 (3): 515–28. doi:10.1016/j.ecl.2013.05.007. PMC 3769686. PMID 24011884.
- Walsh JM, Wheat ME, Freund K (August 2000). "Detection, evaluation, and treatment of eating disorders the role of the primary care physician". Journal of General Internal Medicine. 15 (8): 577–90. doi:10.1046/j.1525-1497.2000.02439.x. PMC 1495575. PMID 10940151.
- Stargrove MB, Treasure J, McKee DL (2008). Herb, Nutrient, and Drug Interactions: Clinical Implications and Therapeutic Strategies. Elsevier Health Sciences. ISBN 978-0-323-02964-3. Retrieved 9 April 2015.
- Nolen-Hoeksema S (2013). Abnormal Psychology. New York: McGraw Hill. pp. 339–41. ISBN 978-0-07-803538-8.
- "Anorexia Nervosa". National Association of Anorexia Nervosa and Associated Disorders. Archived from the original on 13 April 2014. Retrieved 15 April 2014.
- Marzola E, Nasser JA, Hashim SA, Shih PA, Kaye WH (November 2013). "Nutritional rehabilitation in anorexia nervosa: review of the literature and implications for treatment". BMC Psychiatry. 13 (1): 290. doi:10.1186/1471-244X-13-290. PMC 3829207. PMID 24200367.
- Robinson PH (2006). Community treatment of eating disorders. Chichester: John Wiley & Sons. p. 66. ISBN 978-0-470-01676-3.
- Haller E (December 1992). "Eating disorders. A review and update". The Western Journal of Medicine. 157 (6): 658–62. PMC 1022101. PMID 1475950.
- Khalsa SS, Adolphs R, Cameron OG, Critchley HD, Davenport PW, Feinstein JS, et al. (June 2018). "Interoception and Mental Health: A Roadmap". Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3 (6): 501–513. doi:10.1016/j.bpsc.2017.12.004. PMC 6054486. PMID 29884281.
- Badoud D, Tsakiris M (June 2017). "From the body's viscera to the body's image: Is there a link between interoception and body image concerns?". Neuroscience and Biobehavioral Reviews. 77: 237–246. doi:10.1016/j.neubiorev.2017.03.017. PMID 28377099. S2CID 768206.
- Khalsa SS, Lapidus RC (2016). "Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?". Frontiers in Psychiatry. 7: 121. doi:10.3389/fpsyt.2016.00121. PMC 4958623. PMID 27504098.
- Boswell JF, Anderson LM, Anderson DA (June 2015). "Integration of Interoceptive Exposure in Eating Disorder Treatment". Clinical Psychology: Science and Practice. 22 (2): 194–210. doi:10.1111/cpsp.12103.
- Kasperek-Zimowska BJ, Zimowski JG, Biernacka K, Kucharska-Pietura K, Rybakowski F (2014). "Impaired social cognition processes in Asperger syndrome and anorexia nervosa. In search for endophenotypes of social cognition". Psychiatria Polska. 50 (3): 533–42. doi:10.12740/PP/OnlineFirst/33485. PMID 27556112.
- Strober M, Freeman R, Lampert C, Diamond J (November 2007). "The association of anxiety disorders and obsessive compulsive personality disorder with anorexia nervosa: evidence from a family study with discussion of nosological and neurodevelopmental implications". The International Journal of Eating Disorders. 40 Suppl (S3): S46-51. doi:10.1002/eat.20429. PMID 17610248.
- Brand-Gothelf A, Leor S, Apter A, Fennig S (October 2014). "The impact of comorbid depressive and anxiety disorders on severity of anorexia nervosa in adolescent girls". The Journal of Nervous and Mental Disease. 202 (10): 759–62. doi:10.1097/NMD.0000000000000194. PMID 25265267. S2CID 6023688.
- Godier LR, Park RJ (2014). "Compulsivity in anorexia nervosa: a transdiagnostic concept". Frontiers in Psychology. 5: 778. doi:10.3389/fpsyg.2014.00778. PMC 4101893. PMID 25101036.
- Halmi KA, Tozzi F, Thornton LM, Crow S, Fichter MM, Kaplan AS, et al. (December 2005). "The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders". The International Journal of Eating Disorders. 38 (4): 371–4. doi:10.1002/eat.20190. PMID 16231356.
- Crane AM, Roberts ME, Treasure J (November 2007). "Are obsessive-compulsive personality traits associated with a poor outcome in anorexia nervosa? A systematic review of randomized controlled trials and naturalistic outcome studies". The International Journal of Eating Disorders. 40 (7): 581–8. doi:10.1002/eat.20419. PMID 17607713.
- Gárriz M, Andrés-Perpiñá S, Plana MT, Flamarique I, Romero S, Julià L, Castro-Fornieles J (March 2021). "Personality disorder traits, obsessive ideation and perfectionism 20 years after adolescent-onset anorexia nervosa: a recovered study". Eating and Weight Disorders. 26 (2): 667–677. doi:10.1007/s40519-020-00906-7. PMID 32350776. S2CID 216649851.
However, prospective studies are still scarce and the results from current literature regarding causal connections between AN and personality are unavailable.
- Casper RC (1998). "Depression and eating disorders". Depression and Anxiety. 8 Suppl 1 (Suppl 1): 96–104. doi:10.1002/(SICI)1520-6394(1998)8:1+<96::AID-DA15>3.0.CO;2-4. PMID 9809221.
- Zernig G, Saria A, Kurz M, O'Malley S (24 March 2000). Handbook of Alcoholism. CRC Press. p. 293. ISBN 978-1-4200-3696-1.
- Sansone RA, Levitt JL (21 August 2013). Personality Disorders and Eating Disorders: Exploring the Frontier. Routledge. p. 28. ISBN 978-1-135-44280-4.
- Halmi KA (November 2013). "Perplexities of treatment resistance in eating disorders". BMC Psychiatry. 13: 292. doi:10.1186/1471-244X-13-292. PMC 3829659. PMID 24199597.
- Swinbourne JM, Touyz SW (July 2007). "The co-morbidity of eating disorders and anxiety disorders: a review". European Eating Disorders Review. 15 (4): 253–74. doi:10.1002/erv.784. PMID 17676696.
- Cortese S, Bernardina BD, Mouren MC (September 2007). "Attention-deficit/hyperactivity disorder (ADHD) and binge eating". Nutrition Reviews. 65 (9): 404–11. doi:10.1111/j.1753-4887.2007.tb00318.x. PMID 17958207.
- Wilhelm S, Phillips KA, Steketee G (18 December 2012). Cognitive-Behavioral Therapy for Body Dysmorphic Disorder: A Treatment Manual. Guilford Press. p. 270. ISBN 978-1-4625-0790-0.
- Berkman ND, Bulik CM, Brownley KA, Lohr KN, Sedway JA, Rooks A, Gartlehner G (April 2006). "Management of eating disorders" (PDF). Evidence Report/Technology Assessment (135): 1–166. PMC 4780981. PMID 17628126. Archived (PDF) from the original on 22 December 2014.
- Huke V, Turk J, Saeidi S, Kent A, Morgan JF (September 2013). "Autism spectrum disorders in eating disorder populations: a systematic review". European Eating Disorders Review. 21 (5): 345–51. doi:10.1002/erv.2244. PMID 23900859.
- Zucker NL, Losh M, Bulik CM, LaBar KS, Piven J, Pelphrey KA (November 2007). "Anorexia nervosa and autism spectrum disorders: guided investigation of social cognitive endophenotypes" (PDF). Psychological Bulletin. 133 (6): 976–1006. doi:10.1037/0033-2909.133.6.976. PMID 17967091. Archived (PDF) from the original on 20 April 2010.
- Rikani AA, Choudhry Z, Choudhry AM, Ikram H, Asghar MW, Kajal D, et al. (October 2013). "A critique of the literature on etiology of eating disorders". Annals of Neurosciences. 20 (4): 157–61. doi:10.5214/ans.0972.7531.200409. PMC 4117136. PMID 25206042.
- Thornton LM, Mazzeo SE, Bulik CM (2011). "The heritability of eating disorders: methods and current findings". Behavioral Neurobiology of Eating Disorders. Current Topics in Behavioral Neurosciences. 6. pp. 141–56. doi:10.1007/7854_2010_91. ISBN 978-3-642-15130-9. PMC 3599773. PMID 21243474.
- Hildebrandt T, Downey A (4 July 2013). "The Neurobiology of Eating Disorders". In Charney D, Sklar P, Buxbaum J, Nestler E (eds.). Neurobiology of Mental Illness (4th ed.). Oxford University Press. ISBN 9780199934959.
- Rask-Andersen M, Olszewski PK, Levine AS, Schiöth HB (March 2010). "Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake". Brain Research Reviews. 62 (2): 147–64. doi:10.1016/j.brainresrev.2009.10.007. PMID 19931559. S2CID 37635456.
- Pjetri E, Schmidt U, Kas MJ, Campbell IC (July 2012). "Epigenetics and eating disorders". Current Opinion in Clinical Nutrition and Metabolic Care. 15 (4): 330–5. doi:10.1097/MCO.0b013e3283546fd3. PMID 22617563. S2CID 27183934.
- Hübel C, Marzi SJ, Breen G, Bulik CM (June 2019). "Epigenetics in eating disorders: a systematic review". Molecular Psychiatry. 24 (6): 901–915. doi:10.1038/s41380-018-0254-7. PMC 6544542. PMID 30353170.
- Watson HJ, Yilmaz Z, Thornton LM, Hübel C, Coleman JR, Gaspar HA, et al. (August 2019). "Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa". Nature Genetics. 51 (8): 1207–1214. doi:10.1038/s41588-019-0439-2. PMC 6779477. PMID 31308545.
- Larsen JT, Bulik CM, Thornton LM, Koch SV, Petersen L (April 2021). "Prenatal and perinatal factors and risk of eating disorders". Psychological Medicine. 51 (5): 870–880. doi:10.1017/S0033291719003945. PMID 31910913. S2CID 210086516.
- Jones C, Pearce B, Barrera I, Mummert A (September 2017). "Fetal programming and eating disorder risk". Journal of Theoretical Biology. 428: 26–33. doi:10.1016/j.jtbi.2017.05.028. PMID 28571669.
- Favaro, Angela, University of Padova; Tenconi, Elena, University of Padova; Santonastaso, Paolo, University of Padova (February 2006). "Perinatal Factors and the Risk of Developing Anorexia Nervosa and Bulimia Nervosa". Archives of General Psychiatry. 63 (1): 82–8. doi:10.1001/archpsyc.63.1.82. Retrieved 23 June 2021.
- Davis JF, Choi DL, Benoit SC (2011). "24. Orexigenic Hypothalamic Peptides Behavior and Feeding – 24.5 Orexin". In Preedy VR, Watson RR, Martin CR (eds.). Handbook of Behavior, Food and Nutrition. Springer. pp. 361–2. ISBN 978-0-387-92271-3.
- Smitka K, Papezova H, Vondra K, Hill M, Hainer V, Nedvidkova J (2013). "The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa". International Journal of Endocrinology. 2013: 483145. doi:10.1155/2013/483145. PMC 3782835. PMID 24106499.
- Satherley R, Howard R, Higgs S (January 2015). "Disordered eating practices in gastrointestinal disorders" (PDF). Appetite (Review). 84: 240–50. doi:10.1016/j.appet.2014.10.006. PMID 25312748. S2CID 25805182. Archived from the original (PDF) on 24 September 2019. Retrieved 4 July 2019.
- Bern EM, O'Brien RF (August 2013). "Is it an eating disorder, gastrointestinal disorder, or both?". Current Opinion in Pediatrics (Review). 25 (4): 463–70. doi:10.1097/MOP.0b013e328362d1ad. PMID 23838835. S2CID 5417088.
Several case reports brought attention to the association of anorexia nervosa and celiac disease.(...) Some patients present with the eating disorder prior to diagnosis of celiac disease and others developed anorexia nervosa after the diagnosis of celiac disease. Healthcare professionals should screen for celiac disease with eating disorder symptoms especially with gastrointestinal symptoms, weight loss, or growth failure.(...) Celiac disease patients may present with gastrointestinal symptoms such as diarrhea, steatorrhea, weight loss, vomiting, abdominal pain, anorexia, constipation, bloating, and distension due to malabsorption. Extraintestinal presentations include anemia, osteoporosis, dermatitis herpetiformis, short stature, delayed puberty, fatigue, aphthous stomatitis, elevated transaminases, neurologic problems, or dental enamel hypoplasia.(...) it has become clear that symptomatic and diagnosed celiac disease is the tip of the iceberg; the remaining 90% or more of children are asymptomatic and undiagnosed.
- Quick VM, Byrd-Bredbenner C, Neumark-Sztainer D (May 2013). "Chronic illness and disordered eating: a discussion of the literature". Advances in Nutrition (Review). 4 (3): 277–86. doi:10.3945/an.112.003608. PMC 3650496. PMID 23674793.
- Zandian M, Ioakimidis I, Bergh C, Södersten P (September 2007). "Cause and treatment of anorexia nervosa". Physiology & Behavior. 92 (1–2): 283–90. doi:10.1016/j.physbeh.2007.05.052. PMID 17585973. S2CID 43620773.
- Thambirajah MS (2007). Case Studies in Child and Adolescent Mental Health. Radcliffe Publishing. p. 145. ISBN 978-1-85775-698-2. OCLC 84150452.
- Kaye W (April 2008). "Neurobiology of anorexia and bulimia nervosa". Physiology & Behavior. 94 (1): 121–35. doi:10.1016/j.physbeh.2007.11.037. PMC 2601682. PMID 18164737.
- Herpertz-Dahlmann B, Bühren K, Remschmidt H (June 2013). "Growing up is hard: mental disorders in adolescence". Deutsches Ärzteblatt International. 110 (25): 432–9, quiz 440. doi:10.3238/arztebl.2013.0432. PMC 3705204. PMID 23840288.
- Wonderlich SA, Brewerton TD, Jocic Z, Dansky BS, Abbott DW (August 1997). "Relationship of childhood sexual abuse and eating disorders". Journal of the American Academy of Child and Adolescent Psychiatry. 36 (8): 1107–15. doi:10.1097/00004583-199708000-00018. PMID 9256590.
- Connors ME, Morse W (January 1993). "Sexual abuse and eating disorders: a review". The International Journal of Eating Disorders. 13 (1): 1–11. doi:10.1002/1098-108x(199301)13:1<1::aid-eat2260130102>3.0.co;2-p. PMID 8477269.
- Worthen D (2001). P & G Pharmacy Handbook. p. 65.
- Ensminger A (1983). Foods & nutrition encyclopedia. p. 423.
- Colman A (2015). A Dictionary of Psychology. OUP Oxford. p. 851. ISBN 978-0-19-105784-7.
- Textbook of Clinical Gastroenterology and Hepatology (2 ed.). John Wiley & Sons. 2012. p. 69. ISBN 978-1-118-32142-3.
- "Factors That May Contribute to Eating Disorders | National Eating Disorders Association". www.nationaleatingdisorders.org. Archived from the original on 3 March 2016. Retrieved 1 March 2016.
- Halmi KA, Sunday SR, Strober M, Kaplan A, Woodside DB, Fichter M, et al. (November 2000). "Perfectionism in anorexia nervosa: variation by clinical subtype, obsessionality, and pathological eating behavior". The American Journal of Psychiatry. 157 (11): 1799–805. doi:10.1176/appi.ajp.157.11.1799. PMID 11058477.
- Anderluh MB, Tchanturia K, Rabe-Hesketh S, Treasure J (February 2003). "Childhood obsessive-compulsive personality traits in adult women with eating disorders: defining a broader eating disorder phenotype". The American Journal of Psychiatry. 160 (2): 242–7. doi:10.1176/appi.ajp.160.2.242. PMID 12562569.
- "Anorexia Nervosa".
- Flett GL, Newby J, Hewitt PL, Persaud C (September 2011). "Perfectionistic automatic thoughts, trait perfectionism, and bulimic automatic thoughts in young women". Journal of Rational-Emotive & Cognitive-Behavior Therapy. 29 (3): 192–206. doi:10.1007/s10942-011-0135-3. S2CID 144731404.
- Garner DM, Bemis KM (June 1982). "A cognitive-behavioral approach to anorexia nervosa". Cognitive Therapy and Research. 6 (2): 123–50. doi:10.1007/BF01183887. S2CID 10469356.
- "Eating disorders and culture". The Harvard Mental Health Letter. 20 (9): 7. March 2004. PMID 15044128.
- Francisco R (2018), Cuzzolaro M, Fassino S (eds.), "Studies on Body Image, Eating, and Weight in Models, Dancers, and Aesthetic Athletes", Body Image, Eating, and Weight: A Guide to Assessment, Treatment, and Prevention, Springer International Publishing, pp. 401–411, doi:10.1007/978-3-319-90817-5_29, hdl:10400.14/33058, ISBN 978-3-319-90817-5
- Becker AE (2018). "Sociocultural influences on body image and eating disturbance". In Brownell KD, Walsh BT (eds.). Eating Disorders and Obesity: A Comprehensive Handbook (Third ed.). Guilford Publications. pp. 127–133. ISBN 978-1-4625-3609-2.
- Anderson-Fye EP, Becker AE (2004). "Sociocultural Aspects of Eating Disorders". In Thompson KJ (ed.). Handbook of Eating Disorders and Obesity. Hoboken, NJ: John Wiley & Sons. pp. 565–89. ISBN 978-0-471-23073-1.
- Baum A (2006). "Eating disorders in the male athlete" (PDF). Sports Medicine. 36 (1): 1–6. doi:10.2165/00007256-200636010-00001. PMID 16445307. S2CID 15296296. Archived (PDF) from the original on 4 June 2015.
- Kyriacou O, Treasure J, Schmidt U (January 2008). "Expressed emotion in eating disorders assessed via self-report: an examination of factors associated with expressed emotion in carers of people with anorexia nervosa in comparison to control families". The International Journal of Eating Disorders. 41 (1): 37–46. doi:10.1002/eat.20469. PMID 17922532.
- Yager J (April 2020). "Managing Patients With Severe and Enduring Anorexia Nervosa: When Is Enough, Enough?". The Journal of Nervous and Mental Disease. 208 (4): 277–282. doi:10.1097/NMD.0000000000001124. PMID 32221180.
- "Eating Disorders Anorexia Causes | Eating Disorders". Psychiatric Disorders and Mental Health Issues. Archived from the original on 7 March 2016. Retrieved 1 March 2016.
- Labre MP (April 2002). "Adolescent boys and the muscular male body ideal". The Journal of Adolescent Health. 30 (4): 233–42. doi:10.1016/S1054-139X(01)00413-X. PMID 11927235.
- Izydorczyk B, Sitnik-Warchulska K (29 March 2018). "Sociocultural Appearance Standards and Risk Factors for Eating Disorders in Adolescents and Women of Various Ages". Frontiers in Psychology. 9: 429. doi:10.3389/fpsyg.2018.00429. PMC 5885084. PMID 29651268.
- Norris ML, Boydell KM, Pinhas L, Katzman DK (September 2006). "Ana and the Internet: a review of pro-anorexia websites". The International Journal of Eating Disorders. 39 (6): 443–7. doi:10.1002/eat.20305. PMID 16721839.
- Harrison K (2001). "Ourselves, Our Bodies: Thin-Ideal Media, Self-Discrepancies, and Eating Disorder Symptomatology in Adolescents". Journal of Social and Clinical Psychology. 20 (3): 289–323. doi:10.1521/jscp.20.3.289.22303.
- Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC, et al. (May 2005). "Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies". Physiology & Behavior. 85 (1): 73–81. doi:10.1016/j.physbeh.2005.04.013. PMID 15869768. S2CID 25676759.
- Kaye WH, Bailer UF, Frank GK, Wagner A, Henry SE (September 2005). "Brain imaging of serotonin after recovery from anorexia and bulimia nervosa". Physiology & Behavior. 86 (1–2): 15–7. doi:10.1016/j.physbeh.2005.06.019. PMID 16102788. S2CID 17250708.
- Gaudio S, Wiemerslage L, Brooks SJ, Schiöth HB (December 2016). "A systematic review of resting-state functional-MRI studies in anorexia nervosa: Evidence for functional connectivity impairment in cognitive control and visuospatial and body-signal integration". Neuroscience and Biobehavioral Reviews. 71: 578–589. doi:10.1016/j.neubiorev.2016.09.032. PMID 27725172.
- Fuglset TS, Landrø NI, Reas DL, Rø Ø (2016). "Functional brain alterations in anorexia nervosa: a scoping review". Journal of Eating Disorders. 4: 32. doi:10.1186/s40337-016-0118-y. PMC 5125031. PMID 27933159.
- Kaye WH, Wagner A, Fudge JL, Paulus M (2011). "Neurocircuitry of Eating Disorders". In Adan RA, Kaye WH (eds.). Behavioral Neurobiology of Eating Disorders: 6. Current Topics in Behavioral Neurosciences. Springer Berlin Heidelberg. pp. 59–80. ISBN 978-3-642-15131-6.
- Titova OE, Hjorth OC, Schiöth HB, Brooks SJ (April 2013). "Anorexia nervosa is linked to reduced brain structure in reward and somatosensory regions: a meta-analysis of VBM studies". BMC Psychiatry. 13: 110. doi:10.1186/1471-244X-13-110. PMC 3664070. PMID 23570420.
- King JA, Frank GK, Thompson PM, Ehrlich S (February 2018). "Structural Neuroimaging of Anorexia Nervosa: Future Directions in the Quest for Mechanisms Underlying Dynamic Alterations". Biological Psychiatry. 83 (3): 224–234. doi:10.1016/j.biopsych.2017.08.011. PMC 6053269. PMID 28967386.
- Frank GK (August 2015). "Advances from neuroimaging studies in eating disorders". CNS Spectrums. 20 (4): 391–400. doi:10.1017/S1092852915000012. PMC 4989857. PMID 25902917.
- Mitchell JE, Peterson CB (April 2020). "Anorexia Nervosa". The New England Journal of Medicine. 382 (14): 1343–1351. doi:10.1056/NEJMcp1803175. PMID 32242359.
- Estour B, Galusca B, Germain N (2014). "Constitutional thinness and anorexia nervosa: a possible misdiagnosis?". Frontiers in Endocrinology. 5: 175. doi:10.3389/fendo.2014.00175. PMC 4202249. PMID 25368605.
- Peat C, Mitchell JE, Hoek HW, Wonderlich SA (November 2009). "Validity and utility of subtyping anorexia nervosa". The International Journal of Eating Disorders. 42 (7): 590–4. doi:10.1002/eat.20717. PMC 2844095. PMID 19598270.
- Singleton JK (12 November 2014). Primary Care, Second Edition: An Interprofessional Perspective. Springer Publishing Company. ISBN 978-0-8261-7147-4. Retrieved 9 April 2015.
- "CBC". MedlinePlus : U.S. National Library of Medicine. Archived from the original on 25 May 2013. Retrieved 31 May 2013.
- Urinalysis at Medline Archived 4 April 2010 at the Wayback Machine. Nlm.nih.gov (26 January 2012). Retrieved on 4 February 2012.
- Chem-20 at Medline Archived 5 April 2015 at the Wayback Machine. Nlm.nih.gov. Retrieved on 4 February 2012.
- Lee H, Oh JY, Sung YA, Chung H, Cho WY (October 2009). "The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome". Endocrine. 36 (2): 326–32. doi:10.1007/s12020-009-9226-7. PMID 19688613. S2CID 207361456.
- Montagnese C, Scalfi L, Signorini A, De Filippo E, Pasanisi F, Contaldo F (December 2007). "Cholinesterase and other serum liver enzymes in underweight outpatients with eating disorders". The International Journal of Eating Disorders. 40 (8): 746–50. doi:10.1002/eat.20432. PMID 17610252.
- Narayanan V, Gaudiani JL, Harris RH, Mehler PS (May 2010). "Liver function test abnormalities in anorexia nervosa--cause or effect". The International Journal of Eating Disorders. 43 (4): 378–81. doi:10.1002/eat.20690. PMID 19424979.
- Walder A, Baumann P (December 2008). "Increased creatinine kinase and rhabdomyolysis in anorexia nervosa". The International Journal of Eating Disorders. 41 (8): 766–7. doi:10.1002/eat.20548. PMID 18521917.
- BUN at Medline Archived 9 April 2010 at the Wayback Machine. Nlm.nih.gov (26 January 2012). Retrieved on 4 February 2012.
- Sheridan AM, Bonventre JV (July 2000). "Cell biology and molecular mechanisms of injury in ischemic acute renal failure". Current Opinion in Nephrology and Hypertension. 9 (4): 427–34. doi:10.1097/00041552-200007000-00015. PMID 10926180.
- Nelsen DA (December 2002). "Gluten-sensitive enteropathy (celiac disease): more common than you think". American Family Physician. 66 (12): 2259–66. PMID 12507163.
- Pepin J, Shields C (February 2012). "Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies". Emergency Medicine Practice. 14 (2): 1–17, quiz 17–8. PMID 22413702.
- "Electroencephalogram". Medline Plus. 26 January 2012. Archived from the original on 27 January 2012. Retrieved 4 February 2012.
- Misra M, Klibanski A (2011). "The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism". Neuroendocrinology. 93 (2): 65–73. doi:10.1159/000323771. PMC 3214929. PMID 21228564.
- Nolen-Hoeksema S (2014). "Eating disorders". Abnormal Psychology (Sixth ed.). New York: McGraw-Hill Education. p. 341. ISBN 978-0-07-803538-8.
- Lock JD, Fitzpatrick KK (March 2009). "Anorexia nervosa". BMJ Clinical Evidence. 2009. PMC 2907776. PMID 19445758.
- National Institute of Mental Health. "Eating disorders". Archived from the original on 23 March 2015. Retrieved 23 March 2015.
- Gowers SG, Weetman J, Shore A, Hossain F, Elvins R (February 2000). "Impact of hospitalisation on the outcome of adolescent anorexia nervosa". The British Journal of Psychiatry. 176 (2): 138–41. doi:10.1192/bjp.176.2.138. PMID 10755050.
- Nolen-Hoeksema S (2014). Abnormal Psychology (Sixth ed.). McGraw-Hill Education. p. 357. ISBN 978-1-259-06072-4.
- Blessitt E, Voulgari S, Eisler I (November 2015). "Family therapy for adolescent anorexia nervosa". Current Opinion in Psychiatry. 28 (6): 455–60. doi:10.1097/yco.0000000000000193. PMID 26382158. S2CID 33438815.
- Garner DM, Garfinkel PE (1 January 1997). Handbook of Treatment for Eating Disorders. Guilford Press. ISBN 978-1-57230-186-3.
- Whitnet E, Rolfes SR (2011). Understanding Nutrition. United States: Wadsworth Cengage Learning. p. 255. ISBN 978-1-133-58752-1. Archived from the original on 24 November 2015.
- Russell GF, Szmukler GI, Dare C, Eisler I (December 1987). "An evaluation of family therapy in anorexia nervosa and bulimia nervosa". Archives of General Psychiatry. 44 (12): 1047–56. doi:10.1001/archpsyc.1987.01800240021004. PMID 3318754.
- le Grange D, Eisler I (January 2009). "Family interventions in adolescent anorexia nervosa". Child and Adolescent Psychiatric Clinics of North America. 18 (1): 159–73. doi:10.1016/j.chc.2008.07.004. PMID 19014864.
- "Eating Disorders". National Institute of Mental Health (NIMH). 2011. Archived from the original on 1 October 2013. Retrieved 29 September 2013.
- Fisher CA, Skocic S, Rutherford KA, Hetrick SE (May 2019). "Family therapy approaches for anorexia nervosa". The Cochrane Database of Systematic Reviews. 5: CD004780. doi:10.1002/14651858.CD004780.pub4. PMC 6497182. PMID 31041816.
- Whitfield G, Davidson A (2007). Cognitive Behavioural Therapy Explained. Radcliffe Publishing. ISBN 978-1-85775-603-6. Retrieved 9 April 2015.
- Keltner NL, Steele D (6 August 2014). Psychiatric Nursing. Elsevier Health Sciences. ISBN 978-0-323-29352-5. Retrieved 9 April 2015.
- Tchanturia K, Lounes N, Holttum S (November 2014). "Cognitive remediation in anorexia nervosa and related conditions: a systematic review". European Eating Disorders Review. 22 (6): 454–62. doi:10.1002/erv.2326. PMID 25277720.
- Pinna F, Sanna L, Carpiniello B (2015). "Alexithymia in eating disorders: therapeutic implications". Psychology Research and Behavior Management. 8: 1–15. doi:10.2147/PRBM.S52656. PMC 4278740. PMID 25565909.
- Claudino AM, Hay P, Lima MS, Bacaltchuk J, Schmidt U, Treasure J (January 2006). "Antidepressants for anorexia nervosa". The Cochrane Database of Systematic Reviews (1): CD004365. doi:10.1002/14651858.CD004365.pub2. PMID 16437485.
- Meftah AM, Deckler E, Citrome L, Kantrowitz JT (January 2020). "New discoveries for an old drug: a review of recent olanzapine research". Postgraduate Medicine. 132 (1): 80–90. doi:10.1080/00325481.2019.1701823. PMID 31813311. S2CID 208957067.
- Arcelus J, Mitchell AJ, Wales J, Nielsen S (July 2011). "Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies". Archives of General Psychiatry. 68 (7): 724–31. doi:10.1001/archgenpsychiatry.2011.74. PMID 21727255.
- Robinson P (2012). "Avoiding deaths in hospital from anorexia nervosa: the MARSIPAN project". The Psychiatrist. 36 (3): 109–13. doi:10.1192/pb.bp.111.036699.
- Royal_College_of_Psychiatrists (2014). MARSIPAN Archived 21 April 2016 at the Wayback Machine: Management of Really Sick Patients with Anorexia Nervosa. Second edition. Page 6
- O'Connor G, Nicholls D (June 2013). "Refeeding hypophosphatemia in adolescents with anorexia nervosa: a systematic review". Nutrition in Clinical Practice. 28 (3): 358–64. doi:10.1177/0884533613476892. PMC 4108292. PMID 23459608.
- "Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition". NICE. 4 August 2017. Retrieved 8 March 2021.
- Bouquegneau A, Dubois BE, Krzesinski JM, Delanaye P (August 2012). "Anorexia nervosa and the kidney". American Journal of Kidney Diseases. 60 (2): 299–307. doi:10.1053/j.ajkd.2012.03.019. PMID 22609034.
- Nolen-Hoeksema S (2014). "Eating Disorders". Abnormal Psychology (Sixth ed.). New York: McGraw Hill Education. p. 342. ISBN 978-0-07-803538-8.
- Leigh, Suzanne (19 November 2019). "Many Patients with Anorexia Nervosa Get Better, But Complete Recovery Elusive to Most". University of California San Francisco. The Regents of The University of California. Retrieved 23 June 2021.
- Donaldson AA, Gordon CM (10 May 2020). "Skeletal Complications of Eating Disorders". Metabolism. Metabolism: Clinical and Experimental. 64 (9): 943–951. doi:10.1016/j.metabol.2015.06.007. PMC 4546560. PMID 26166318.
- "Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders" (PDF). National Collaborating Centre for Mental Health. 2004. Archived (PDF) from the original on 27 March 2014.
- Vyver E, Steinegger C, Katzman DK (2008). "Eating disorders and menstrual dysfunction in adolescents". Annals of the New York Academy of Sciences. 1135 (1): 253–64. Bibcode:2008NYASA1135..253V. doi:10.1196/annals.1429.013. PMID 18574232. S2CID 42042720.
- Devlin MJ, Walsh BT, Katz JL, Roose SP, Linkie DM, Wright L, et al. (April 1989). "Hypothalamic-pituitary-gonadal function in anorexia nervosa and bulimia". Psychiatry Research. 28 (1): 11–24. doi:10.1016/0165-1781(89)90193-5. PMID 2500676. S2CID 39940665.
- Støving RK, Chen JW, Glintborg D, Brixen K, Flyvbjerg A, Hørder K, Frystyk J (June 2007). "Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa". The Journal of Clinical Endocrinology and Metabolism. 92 (6): 2323–9. doi:10.1210/jc.2006-1926. PMID 17389700.
- Misra M, Klibanski A (June 2014). "Anorexia nervosa and bone". The Journal of Endocrinology. 221 (3): R163-76. doi:10.1530/JOE-14-0039. PMC 4047520. PMID 24898127.
- Kleinman R (1 April 2008). Walker's Pediatric Gastrointestinal Disease. PMPH-USA. ISBN 978-1-55009-364-3. Retrieved 9 April 2015.
- Norris ML, Harrison ME, Isserlin L, Robinson A, Feder S, Sampson M (March 2016). "Gastrointestinal complications associated with anorexia nervosa: A systematic review". The International Journal of Eating Disorders. 49 (3): 216–37. doi:10.1002/eat.22462. PMID 26407541.
- Sachs KV, Harnke B, Mehler PS, Krantz MJ (March 2016). "Cardiovascular complications of anorexia nervosa: A systematic review". The International Journal of Eating Disorders. 49 (3): 238–48. doi:10.1002/eat.22481. PMID 26710932.
- Goldberg SJ, Comerci GD, Feldman L (January 1988). "Cardiac output and regional myocardial contraction in anorexia nervosa". Journal of Adolescent Health Care. 9 (1): 15–21. doi:10.1016/0197-0070(88)90013-7. PMID 3335466.
- Johnson GL, Humphries LL, Shirley PB, Mazzoleni A, Noonan JA (August 1986). "Mitral valve prolapse in patients with anorexia nervosa and bulimia". Archives of Internal Medicine. 146 (8): 1525–9. doi:10.1001/archinte.1986.00360200083014. PMID 3460535.
- Hasan TF, Hasan H (2011). "Anorexia nervosa: a unified neurological perspective". International Journal of Medical Sciences. 8 (8): 679–703. doi:10.7150/ijms.8.679. PMC 3204438. PMID 22135615.
- Zanetti T (2013). "Epidemiology of Eating Disorders". Eating Disorders and the Skin. pp. 9–15. doi:10.1007/978-3-642-29136-4_2. ISBN 978-3-642-29135-7.
- Radford B (2018). "Medical Misinformation in the Media: Is Anorexia on the Rise?" (PDF). Skeptical Inquirer. Committee for Skeptical Inquirer. 42 (1): 46–49.
- Makino M, Tsuboi K, Dennerstein L (September 2004). "Prevalence of eating disorders: a comparison of Western and non-Western countries". MedGenMed. 6 (3): 49. PMC 1435625. PMID 15520673.
- Bonci CM, Bonci LJ, Granger LR, Johnson CL, Malina RM, Milne LW, et al. (2008). "National athletic trainers' association position statement: preventing, detecting, and managing disordered eating in athletes". Journal of Athletic Training. 43 (1): 80–108. doi:10.4085/1062-6050-43.1.80. PMC 2231403. PMID 18335017.
- Thiel A, Gottfried H, Hesse FW (October 1993). "Subclinical eating disorders in male athletes. A study of the low weight category in rowers and wrestlers". Acta Psychiatrica Scandinavica. 88 (4): 259–65. doi:10.1111/j.1600-0447.1993.tb03454.x. PMID 8256643. S2CID 10232724.
- Crilly L (2 April 2012). Hope with Eating Disorders. Hay House, Inc. ISBN 978-1-84850-906-1. Retrieved 9 April 2015.
- "Eating Disorders in Men & Boys". National Eating Disorders Association. 25 February 2017. Retrieved 11 June 2021.
- Striegel-Moore, Ruth H.; Rosselli, Francine; Perrin, Nancy; DeBar, Lynn G.; Wilson, Terence; May, Alexis; Kraemer, Helena C. (2009). "Gender Difference in the Prevalence of Eating Disorder Symptoms". International Journal of Eating Disorders. 42 (5): 471–474. doi:10.1002/eat.20625. PMC 2696560. PMID 19107833.
- Pearce JM (2004). "Richard Morton: origins of anorexia nervosa". European Neurology. 52 (4): 191–2. doi:10.1159/000082033. PMID 15539770. S2CID 30482453.
- Espi Forcen F (April 2013). "Anorexia mirabilis: the practice of fasting by Saint Catherine of Siena in the late Middle Ages". The American Journal of Psychiatry. 170 (4): 370–1. doi:10.1176/appi.ajp.2012.12111457. PMID 23545792.
- Harris JC (November 2014). "Anorexia nervosa and anorexia mirabilis: Miss K. R--and St Catherine Of Siena". JAMA Psychiatry. 71 (11): 1212–3. doi:10.1001/jamapsychiatry.2013.2765. PMID 25372187.
- Gull WW (1894). Acland TD (ed.). Medical Papers. p. 309.
- Lasègue E (6 September 1873). "On Hysterical Anorexia". Medical Times and Gazette. See also Laségue (September 1997). "On hysterical anorexia (a). 1873". Obesity Research. 5 (5): 492–7. doi:10.1002/j.1550-8528.1997.tb00676.x. PMID 9385627.
- Arnold C (2012). Decoding Anorexia: How Breakthroughs in Science Offer Hope for Eating Disorders. Routledge Press. ISBN 978-0-415-89867-6.
- Arnold C (29 March 2016). "Anorexia: you don't just grow out of it". The Guardian. Archived from the original on 29 March 2016. Retrieved 29 March 2016.
- Klein DA, Walsh BT (April 2004). "Eating disorders: clinical features and pathophysiology". Physiology & Behavior. 81 (2): 359–74. doi:10.1016/j.physbeh.2004.02.009. PMID 15159176. S2CID 29361114.
- Bailey AP, Parker AG, Colautti LA, Hart LM, Liu P, Hetrick SE (2014). "Mapping the evidence for the prevention and treatment of eating disorders in young people". Journal of Eating Disorders. 2 (1): 5. doi:10.1186/2050-2974-2-5. PMC 4081733. PMID 24999427.
- Coelho GM, Gomes AI, Ribeiro BG, Soares E (2014). "Prevention of eating disorders in female athletes". Open Access Journal of Sports Medicine. 5: 105–13. doi:10.2147/OAJSM.S36528. PMC 4026548. PMID 24891817.
- Luca A, Luca M, Calandra C (February 2015). "Eating Disorders in Late-life". Aging and Disease. 6 (1): 48–55. doi:10.14336/AD.2014.0124. PMC 4306473. PMID 25657852.
|Wikimedia Commons has media related to Anorexia nervosa.|
|Wikiquote has quotations related to: Anorexia nervosa|
- National Association of Anorexia Nervosa and Associated Disorders
- Society of Clinical Psychology—Anorexia